Compare Jubilant Pharmova with ALEMBIC - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs ALEMBIC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT PHARMOVA ALEMBIC JUBILANT PHARMOVA /
ALEMBIC
 
P/E (TTM) x 12.7 191.2 6.7% View Chart
P/BV x 2.1 1.3 160.7% View Chart
Dividend Yield % 0.8 0.2 467.7%  

Financials

 JUBILANT PHARMOVA    ALEMBIC
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-21
ALEMBIC
Mar-21
JUBILANT PHARMOVA /
ALEMBIC
5-Yr Chart
Click to enlarge
High Rs1,047123 852.7%   
Low Rs25132 784.8%   
Sales per share (Unadj.) Rs559.12.9 19,528.9%  
Earnings per share (Unadj.) Rs51.80.5 9,601.7%  
Cash flow per share (Unadj.) Rs80.10.7 11,569.0%  
Dividends per share (Unadj.) Rs5.000.20 2,500.0%  
Avg Dividend yield %0.80.3 298.1%  
Book value per share (Unadj.) Rs297.689.5 332.7%  
Shares outstanding (eoy) m159.28256.78 62.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.227.0 4.3%   
Avg P/E ratio x12.5143.5 8.7%  
P/CF ratio (eoy) x8.1111.7 7.2%  
Price / Book Value ratio x2.20.9 252.1%  
Dividend payout %9.737.1 26.0%   
Avg Mkt Cap Rs m103,36519,868 520.2%   
No. of employees `000NANA-   
Total wages/salary Rs m21,728226 9,616.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m89,055735 12,113.7%  
Other income Rs m298109 273.3%   
Total revenues Rs m89,354844 10,582.8%   
Gross profit Rs m18,699104 17,932.8%  
Depreciation Rs m4,51639 11,463.1%   
Interest Rs m2,4734 68,311.9%   
Profit before tax Rs m12,008170 7,046.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,76432 11,762.5%   
Profit after tax Rs m8,244138 5,955.9%  
Gross profit margin %21.014.2 148.0%  
Effective tax rate %31.318.8 166.9%   
Net profit margin %9.318.8 49.2%  
BALANCE SHEET DATA
Current assets Rs m29,5251,021 2,891.9%   
Current liabilities Rs m10,488594 1,765.3%   
Net working cap to sales %21.458.1 36.8%  
Current ratio x2.81.7 163.8%  
Inventory Days Days1310,191 0.1%  
Debtors Days Days34686 4.9%  
Net fixed assets Rs m58,10923,069 251.9%   
Share capital Rs m159514 31.0%   
"Free" reserves Rs m47,24822,457 210.4%   
Net worth Rs m47,40722,970 206.4%   
Long term debt Rs m25,6400-   
Total assets Rs m87,63424,090 363.8%  
Interest coverage x5.948.1 12.2%   
Debt to equity ratio x0.50-  
Sales to assets ratio x1.00 3,329.9%   
Return on assets %12.20.6 2,074.1%  
Return on equity %17.40.6 2,885.8%  
Return on capital %19.80.8 2,616.5%  
Exports to sales %01.5 0.0%   
Imports to sales %10.26.1 168.9%   
Exports (fob) Rs mNA11 0.0%   
Imports (cif) Rs m9,11745 20,455.5%   
Fx inflow Rs m11,20711 103,385.6%   
Fx outflow Rs m9,11745 20,455.5%   
Net fx Rs m2,090-34 -6,196.3%   
CASH FLOW
From Operations Rs m17,843-22 -81,772.0%  
From Investments Rs m-7,390-347 2,127.4%  
From Financial Activity Rs m-17,094-154 11,127.4%  
Net Cashflow Rs m-7,289-523 1,394.1%  

Share Holding

Indian Promoters % 49.7 70.9 70.0%  
Foreign collaborators % 4.4 0.0 -  
Indian inst/Mut Fund % 26.5 6.1 438.0%  
FIIs % 20.1 1.3 1,545.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 46.0 29.1 157.9%  
Shareholders   37,495 77,201 48.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT PHARMOVA With:   DIVIS LABORATORIES  CADILA HEALTHCARE  ZIM LABORATORIES  GSK PHARMA  BAL PHARMA  



Today's Market

Indian Indices End Flat; Nestle, HDFC and ICICI Bank Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 24.0% YoY). Sales on the other hand came in at Rs 23 bn (down 2.6% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9% (Quarterly Result Update)

Oct 31, 2019 | Updated on Oct 31, 2019

For the quarter ended September 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 18.9% YoY). Sales on the other hand came in at Rs 23 bn (down 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

5 Specialty Chemical Stocks that Turned Multibaggers in One Year(Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

A Rare Buying Opportunity in an Exciting Stock(Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

How to Create a Second Income from Trading(Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

5 Indian Companies with Over 7% in Dividend Yield(Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT PHARMOVA SHARE PRICE


Sep 22, 2021 (Close)

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA 8-QTR ANALYSIS

COMPARE JUBILANT PHARMOVA WITH

MARKET STATS